The Other MMA Drug Benefit: Changes to Reimbursement for Medicare Part B Drugs

The American Health Lawyers Association is hosting a teleconference entitled

The Other MMA Drug Benefit: Changes to Reimbursement for Medicare Part B Drugs
Thursday, September 29, 2005
1:00-2:30 pm Eastern; 12:00-1:30 pm Central; 11:00 am–12:30 pm Mountain; 10:00-11:30 am Pacific

Register online or call the Member Service Center at (202) 833-0766. Registrations must be received by 5:00 on September 28.

Although the new Medicare Part D drug benefit has received much attention as of late, recent changes to reimbursement for drugs reimbursed under Medicare Part B have a far larger impact on hospitals, physicians, and other healthcare providers and suppliers. After much scrutiny by Congress, OIG, and others for over a decade, Congress effected major changes to Part B drug reimbursement in the Medicare Modernization Act of 2003. In large part, these changes reduce payments to entities and individuals that submit claims for Part B drugs, but there may be some opportunities for some. While affected parties struggle to protect their bottom lines in light of these changes, they must also consider the additional compliance risks that are an integral part of the complete overhaul of the prior system.

This teleconference discusses how the changes brought about by the MMA, as implemented by CMS, affect various healthcare entities and individuals.